GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Medico Remedies Ltd

Medico Remedies: Q2 FY27 Unaudited Financial Results Approved, Cost Auditor Appointed

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 09 Nov 2026, 05:17 PM IST  ·  BSE ID: 34dc2dc1-6453-47bb-a4d2-7c7e5a68ed3e
View Original BSE Filing (PDF)
💡
In Simple Terms
The company approved its Q2 FY27 financial results and appointed an auditor for its cost records for FY27.
🤖 AI Summary
  • Board approved Unaudited Standalone Financial Results for the quarter and half year ended 30th September 2026.
  • M/s V. J. Talati & Co. appointed as Cost Auditors for the company for the financial year ending 31st March 2027.
  • A Postal Ballot Notice was approved by the Board of Directors.
  • The Board Meeting commenced at 4:30 P.M. and concluded at 5:15 P.M. on 9th November 2026.
🏢 How This Affects the Company
⚙️
Operational Impact
The appointment of Cost Auditors ensures compliance with regulatory requirements regarding cost accounting records for the financial year ending 31st March 2027.
⚠️
Risk Impact
The appointment of a Cost Auditor and approval of financial results indicates adherence to regulatory compliance and governance standards, potentially reducing regulatory scrutiny risks.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any immediate action based on this specific filing.
👤
Who Is Affected
All shareholders are affected as the company maintains statutory compliance and prepares for future financial reporting and potential resolutions via Postal Ballot.
🔍
Management Signal
Management is signaling a commitment to regulatory compliance and timely financial reporting by approving quarterly results and appointing statutory auditors.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — review revenue and profit trends.
Details of Postal Ballot Notice — understand proposed resolutions.
Annual General Meeting for FY27 — assess key management decisions.
LOW RISK The filing primarily reports routine board approvals and compliance actions, presenting no immediate or new financial risks.
💡 Investor Takeaway
Medico Remedies Ltd's Board approved the unaudited standalone financial results for Q2 FY27 (period ended 30th September 2026). The company also appointed M/s V. J. Talati & Co. as Cost Auditors for FY27 and approved a Postal Ballot Notice.
⚖️ Strengths & Concerns

✅ Positives

  • Timely approval of Unaudited Standalone Financial Results for Q2 FY27 demonstrates adherence to reporting timelines.
  • Appointment of Cost Auditors for FY27 confirms compliance with Companies Act, 2013 provisions for cost audit requirements.
📅 Company Track Record
A previous filing on 2026-05-15 informed BSE that Medico Remedies Ltd's board would meet on May 21, 2026, to consider FY26 financial results, indicating a consistent pattern of board meetings for financial disclosures.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What financial results did Medico Remedies Ltd's board approve?
Medico Remedies Ltd's Board approved the Unaudited Standalone Financial Results for the quarter and half year ended 30th September 2026.
Who was appointed as the Cost Auditor for Medico Remedies Ltd?
M/s V. J. Talati & Co. was appointed as the Cost Auditors of Medico Remedies Ltd for the financial year ending 31st March 2027.
What other resolutions were approved by Medico Remedies Ltd's board?
The Board of Directors also approved a Postal Ballot Notice during their meeting on 9th November 2026.
When did Medico Remedies Ltd's board meeting conclude?
The Board Meeting of Medico Remedies Ltd concluded at 5:15 P.M. on 9th November 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.